6 results about "Pitavastatin" patented technology

The present invention provides the use of a reagent for detecting a target compound combination in the preparation of a detection agent, and the detection agent is used for screening and identifying whether a subject under test has taken drugs for treating vertigo, syncope or stroke, and assisting in determining whether the subject suffers from related diseases. Among them, the target compound combination includes one, several or all of lidocaine, cinepazide maleate, ticlopidine, penbutolol, fendiline, cinnarizine, clopidogrel, midodrine, dipyridamole, argatroban, rosuvastatin, atorvastatin, fluvastatin, and pitavastatin. The plasma sample pretreatment method of the present invention is simple, the detection and analysis time is short, the sensitivity of the method is high, and the types and quantities of detections are many; the method is divided into a primary screening method and a review method, which can improve the accuracy of the detection results and avoid false negative and false positive results.

A method of treating a wound may include topically administering a statin composition including a statin selected from atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin, or combination thereof. The statin composition may be administered in an ointment, powder, or liquid format. The method may also include topically administering one or more antimicrobial drugs and / or naltrexone.

A solid oral pharmaceutical composition, comprising: a first active ingredient, which is pitavastatin or a pharmaceutically acceptable salt thereof, and a second active ingredient, which is a pharmaceutically acceptable salt thereof; the second active ingredient is ezetimibe or a pharmaceutically acceptable salt of the ezetimibe; and at least one excipient comprising a diluent, a stabilizer, a disintegrating agent, an adhesive, a sweetener, a lubricant, a glidant, a perfume, a colorant or a combination thereof.

A method of treating a wound may include topically administering a statin composition including a statin selected from atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin, or combination thereof. The statin composition may be administered in an ointment, powder, or liquid format. The method may also include topically administering one or more antimicrobial drugs and / or naltrexone.

A method is provided for treatment of atherosclerotic cardiovascular disease in a subject in need thereof by administering a statin pharmaceutical composition to the subject when the subject is qualified for over-the-counter access to the statin pharmaceutical composition. In some embodiments, the statin pharmaceutical composition includes atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, or simvastatin as an active ingredient.